184 related articles for article (PubMed ID: 26064179)
1. A novel anti-inflammatory natural product from Sphaeranthus indicus inhibits expression of VCAM1 and ICAM1, and slows atherosclerosis progression independent of lipid changes.
Srivastava RA; Mistry S; Sharma S
Nutr Metab (Lond); 2015; 12():20. PubMed ID: 26064179
[TBL] [Abstract][Full Text] [Related]
2. Artesunate attenuated progression of atherosclerosis lesion formation alone or combined with rosuvastatin through inhibition of pro-inflammatory cytokines and pro-inflammatory chemokines.
Jiang W; Cen Y; Song Y; Li P; Qin R; Liu C; Zhao Y; Zheng J; Zhou H
Phytomedicine; 2016 Oct; 23(11):1259-66. PubMed ID: 27316397
[TBL] [Abstract][Full Text] [Related]
3. Curcumin modulation of high fat diet-induced atherosclerosis and steatohepatosis in LDL receptor deficient mice.
Hasan ST; Zingg JM; Kwan P; Noble T; Smith D; Meydani M
Atherosclerosis; 2014 Jan; 232(1):40-51. PubMed ID: 24401215
[TBL] [Abstract][Full Text] [Related]
4. Progression and Characterization of the Accelerated Atherosclerosis in Iliac Artery of New Zealand White Rabbits: Effect of Simvastatin.
Kanshana JS; Khanna V; Singh V; Jain M; Misra A; Kumar S; Farooqui M; Barthwal MK; Dikshit M
J Cardiovasc Pharmacol; 2017 May; 69(5):314-325. PubMed ID: 28207427
[TBL] [Abstract][Full Text] [Related]
5. Anti-tumor necrosis factor-α therapy increases plaque burden in a mouse model of experimental atherosclerosis.
Oberoi R; Vlacil AK; Schuett J; Schösser F; Schuett H; Tietge UJF; Schieffer B; Grote K
Atherosclerosis; 2018 Oct; 277():80-89. PubMed ID: 30176568
[TBL] [Abstract][Full Text] [Related]
6. The effect of tocopheryl phosphates (TPM) on the development of atherosclerosis in apolipoprotein-E deficient mice.
Libinaki R; Vinh A; Tesanovic-Klajic S; Widdop R; Gaspari T
Clin Exp Pharmacol Physiol; 2017 Dec; 44 Suppl 1():107-116. PubMed ID: 28744946
[TBL] [Abstract][Full Text] [Related]
7. Hematein inhibits atherosclerosis by inhibition of reactive oxygen generation and NF-kappaB-dependent inflammatory mediators in hyperlipidemic mice.
Choi JH; Jeong TS; Kim DY; Kim YM; Na HJ; Nam KH; Lee SB; Kim HC; Oh SR; Choi YK; Bok SH; Oh GT
J Cardiovasc Pharmacol; 2003 Aug; 42(2):287-95. PubMed ID: 12883334
[TBL] [Abstract][Full Text] [Related]
8. Combination therapy with cilostazol and pravastatin improves antiatherogenic effects in low-density lipoprotein receptor knockout mice.
Park KY; Heo TH
Cardiovasc Ther; 2018 Dec; 36(6):e12476. PubMed ID: 30378752
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of cytokine-induced IkappaB kinase activation as a mechanism contributing to the anti-atherogenic activity of tilianin in hyperlipidemic mice.
Nam KW; Kim J; Hong JJ; Choi JH; Mar W; Cho MH; Kim YM; Oh SR; Lee HK; Nam KH; Oh GT
Atherosclerosis; 2005 May; 180(1):27-35. PubMed ID: 15823272
[TBL] [Abstract][Full Text] [Related]
10. Peroxisome proliferator-activated receptor-alpha selective ligand reduces adiposity, improves insulin sensitivity and inhibits atherosclerosis in LDL receptor-deficient mice.
Srivastava RA; Jahagirdar R; Azhar S; Sharma S; Bisgaier CL
Mol Cell Biochem; 2006 Apr; 285(1-2):35-50. PubMed ID: 16477380
[TBL] [Abstract][Full Text] [Related]
11. Skin-Derived Mesenchymal Stem Cells Alleviate Atherosclerosis via Modulating Macrophage Function.
Li Q; Sun W; Wang X; Zhang K; Xi W; Gao P
Stem Cells Transl Med; 2015 Nov; 4(11):1294-301. PubMed ID: 26400926
[TBL] [Abstract][Full Text] [Related]
12. Dihydromyricetin ameliorates atherosclerosis in LDL receptor deficient mice.
Liu TT; Zeng Y; Tang K; Chen X; Zhang W; Xu XL
Atherosclerosis; 2017 Jul; 262():39-50. PubMed ID: 28500865
[TBL] [Abstract][Full Text] [Related]
13. Danhong injection inhibits the development of atherosclerosis in both Apoe⁻/⁻ and Ldlr⁻/⁻ mice.
Chen Y; Liu M; Zhao T; Zhao B; Jia L; Zhu Y; Zhang B; Gao X; Li G; Li X; Xiang R; Han J; Duan Y
J Cardiovasc Pharmacol; 2014 May; 63(5):441-52. PubMed ID: 24803317
[TBL] [Abstract][Full Text] [Related]
14. Dietary Cholesterol Is Highly Associated with Severity of Hyperlipidemia and Atherosclerotic Lesions in Heterozygous LDLR-Deficient Hamsters.
Wang J; He K; Yang C; Lin X; Zhang X; Wang Y; Liu G; Xian X
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31323736
[TBL] [Abstract][Full Text] [Related]
15. A Proinflammatory Gut Microbiota Increases Systemic Inflammation and Accelerates Atherosclerosis.
Brandsma E; Kloosterhuis NJ; Koster M; Dekker DC; Gijbels MJJ; van der Velden S; Ríos-Morales M; van Faassen MJR; Loreti MG; de Bruin A; Fu J; Kuipers F; Bakker BM; Westerterp M; de Winther MPJ; Hofker MH; van de Sluis B; Koonen DPY
Circ Res; 2019 Jan; 124(1):94-100. PubMed ID: 30582442
[TBL] [Abstract][Full Text] [Related]
16. Prevention of Diet-Induced Metabolic Dysregulation, Inflammation, and Atherosclerosis in
Samsoondar JP; Burke AC; Sutherland BG; Telford DE; Sawyez CG; Edwards JY; Pinkosky SL; Newton RS; Huff MW
Arterioscler Thromb Vasc Biol; 2017 Apr; 37(4):647-656. PubMed ID: 28153881
[TBL] [Abstract][Full Text] [Related]
17. Longxuetongluo capsule inhibits atherosclerosis progression in high-fat diet-induced ApoE
Zheng J; Liu B; Lun Q; Gu X; Pan B; Zhao Y; Xiao W; Li J; Tu P
Atherosclerosis; 2016 Dec; 255():156-163. PubMed ID: 27591127
[TBL] [Abstract][Full Text] [Related]
18. Primary prevention of atherosclerosis by pretreatment of low-density lipoprotein receptor knockout mice with sesame oil and its aqueous components.
Aluganti Narasimhulu C; Burge KY; Doomra M; Riad A; Parthasarathy S
Sci Rep; 2018 Aug; 8(1):12270. PubMed ID: 30115989
[TBL] [Abstract][Full Text] [Related]
19. Loss of Macrophage Low-Density Lipoprotein Receptor-Related Protein 1 Confers Resistance to the Antiatherogenic Effects of Tumor Necrosis Factor-α Inhibition.
Zhu L; Giunzioni I; Tavori H; Covarrubias R; Ding L; Zhang Y; Ormseth M; Major AS; Stafford JM; Linton MF; Fazio S
Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1483-95. PubMed ID: 27365402
[TBL] [Abstract][Full Text] [Related]
20. Nuclear factor E2-related factor 2 deficiency impairs atherosclerotic lesion development but promotes features of plaque instability in hypercholesterolaemic mice.
Ruotsalainen AK; Lappalainen JP; Heiskanen E; Merentie M; Sihvola V; Näpänkangas J; Lottonen-Raikaslehto L; Kansanen E; Adinolfi S; Kaarniranta K; Ylä-Herttuala S; Jauhiainen M; Pirinen E; Levonen AL
Cardiovasc Res; 2019 Jan; 115(1):243-254. PubMed ID: 29917052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
